AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Development of a serological assay to predict graft loss in kidney transplant candidates

Summary: Emmanuel Zorn, Ph.D.

Technology Benefits: Complementary to exiting diagnostic tests.Serum reactivity to apoptotic cells may have application in other solid organ transplant procedures and other chronic diseases.Patent information:Patent PendingTech Ventures Reference: IR CU14858

Technology Application: Screening assay for kidney transplant candidates by predicting likelihood of graft loss.

Detailed Technology Description: Emmanuel Zorn, Ph.D.

*Abstract: None

*Inquiry: Peter GolikovColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*IR: CU14358

*Principal Investigator

*Publications: Gao B., Moore C., Porcheray F., Rong C., Abidoglu A., DeVito J., Paine R., Girouard T.C., Saidman S.L., Schoenfeld D., Levin B., Wong W., Elias N., Schuetz C., Rosales I.A., Fu Y. and Zorn E. "Pre-Transplant IgG Reactivity to Apoptotic Cells Correlates with Late kidney Allograft Loss." American J. Transplant. July 2014; 14(7):1581-1591.

Country/Region: USA

For more information, please click Here